Galectin Therapeutics Inc.
GALT
$2.41
$0.010.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 89.89% | 17.20% | -57.41% | -46.20% | -68.45% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.78% | -19.57% | -25.03% | -1.95% | -2.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00% | -- | -- | -- |
| Total Current Assets | 68.99% | 12.66% | -55.60% | -43.46% | -63.53% |
|
|
|||||
| Total Current Assets | 68.99% | 12.66% | -55.60% | -43.46% | -63.53% |
| Net Property, Plant & Equipment | -- | -- | 42.31% | -99.71% | 46.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -61.58% | -69.55% | -64.64% | -47.48% | -54.03% |
| Total Assets | 65.40% | 11.64% | -55.60% | -43.58% | -63.20% |
|
|
|||||
| Total Accounts Payable | -52.23% | -42.63% | 92.84% | 58.60% | 72.08% |
| Total Accrued Expenses | -38.77% | -42.58% | -56.72% | -55.66% | -22.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -99.99% | -99.90% | 1,055.50% | 18.18% | 202,981.25% |
| Total Finance Division Other Current Liabilities | -- | 0.00% | -- | 0.00% | -- |
| Total Other Current Liabilities | -- | 0.00% | -- | 0.00% | -- |
| Total Current Liabilities | -93.41% | -77.32% | 440.21% | -26.29% | 777.38% |
|
|
|||||
| Total Current Liabilities | -93.41% | -77.32% | 440.21% | -26.29% | 777.38% |
| Long-Term Debt | 1,166.68% | 61.70% | -- | 30.59% | -87.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.88% | 20.87% | 12.34% | 20.92% | 25.59% |
|
|
|||||
| Common Stock & APIC | 2.86% | 2.65% | 2.15% | 1.85% | 1.41% |
| Retained Earnings | -6.43% | -7.71% | -9.61% | -10.69% | -12.38% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.68% | -21.95% | -32.83% | -41.50% | -56.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -0.90% | -0.45% | -0.45% | -0.45% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -0.90% | -0.45% | -0.45% | -0.45% | 0.00% |
|
|
|||||
| Total Common Equity | -15.68% | -21.95% | -32.83% | -41.50% | -56.17% |
| Total Preferred Equity | -0.90% | -0.45% | -0.45% | -0.45% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.01% | -22.44% | -33.63% | -42.63% | -57.92% |
|
|
|||||